Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
RESEARCH TOOLSreports
Holding ESTA?
Track your performance easily
ESTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.01 - $60.12
Previous Close$40.01
Volume374.38K
Average Volume (3M)506.95K
Market Cap
$1.12B
Enterprise Value$1.28B
Total Cash (Recent Filing)$39.70M
Total Debt (Recent Filing)$198.19M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Mar 04, 2025EPS Estimate
-$0.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.58
Shares Outstanding27,997,883
10 Day Avg. Volume501,241
30 Day Avg. Volume506,949
Standard Deviation0.17
R-Squared0.13
Alpha0.00981
Financial Highlights & Ratios
Price to Book (P/B)34.20
Price to Sales (P/S)7.12
Price to Cash Flow (P/CF)-21.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.35
Enterprise Value/Gross Profit11.95
Enterprise Value/Ebitda-31.71
Forecast
1Y Price Target
$62.33Price Target Upside55.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Establishment Labs Holdings News
PremiumCompany Announcements
Establishment Labs Reports Narrowed Losses and FDA Approval
PremiumCompany Announcements
Establishment Labs Announces $50M Direct Offering
Bulls Say, Bears Say
Bulls Say
Financial StrategyThe company bolstered the balance sheet with a $25M credit facility draw and a $50M equity offering which removes the capital raise overhang.
Market PerformanceEarly reception of Motiva in US markets has been bullish, comfortably ahead of expectations.
Regulatory ApprovalMotiva FDA clearance is considered a 'game-changer' for the company's story.
Bears Say
Market WeaknessESTA shares are still off -30% from highs achieved earlier in the year predominantly linked to ongoing market weakness across the aesthetics space.
Regional ChallengesESTA does not expect Brazil to improve and thinks LatAm will remain challenging.
Sales GuidanceShares fell approximately 8% following the 3Q print due to lowered sales guidance for 2024 and ongoing weakness in certain markets.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ESTA FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was $24.01 and its highest was $60.12 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Currently, no data Available
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is Mar 04, 2025 which is in 73 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on Nov 07, 2024. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.615 by $0.025.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -$0.64.
How many shares outstanding does Establishment Labs Holdings Inc have?
Establishment Labs Holdings Inc has 28,763,578 shares outstanding.
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.615. Following the earnings report the stock price went down -3.886%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Among the largest hedge funds holding Establishment Labs Holdings Inc’s share is Royce & Associates LLC. It holds Establishment Labs Holdings Inc’s shares valued at N/A.
---
Establishment Labs Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$62.33 (55.79% Upside)
$62.33 (55.79% Upside)
Blogger Sentiment
Bullish
ESTA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 97.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
73.27%
12-Months-Change
Fundamentals
Return on Equity
-223.45%
Trailing 12-Months
Asset Growth
4.49%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
---
ESTA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong performance in the U.S. market following the FDA approval of Motiva Implants, alongside significant financial strengthening and cost reductions. However, challenges persist in Latin America and supply chain issues are present. Despite these challenges, the company is positioned for growth and profitability in 2025.Read More>---
ESTA Stock 12 Month Forecast
Average Price Target
$62.33
▲(55.79% Upside)
Technical Analysis
Best Analysts Covering ESTA
1 Year
1 Year Success Rate
17/44 ratings generated profit
1 Year Average Return
+40.51%
reiterated a buy rating last month
Copying Marie Thibault's trades and holding each position for 1 Year would result in 38.64% of your transactions generating a profit, with an average return of +40.51% per trade.
---